The management of neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors: challenges, progress, and future prospects

Keyphrases

• Neurofibromatosis Type I 100%
• Neurofibromatosis Type 1 (NF-1) 100%
• Malignant Peripheral Nerve Sheath Tumor (MPNST) 100%
• Tumor Challenge 100%
• Tumor 75%
• Malignancy 50%
• Treatment Options 25%
• Collaborative Care 25%
• High Mortality Rate 25%
• Patient Response 25%
• Current Treatment 25%
• Tumor Development 25%
• Therapeutic Potential 25%
• Tumor Progression 25%
• Investigational Treatments 25%
• Sarcoma 25%
• Expert Opinion 25%
• Highly Aggressive 25%
• Difficult-to-treat 25%
• Molecular Etiology 25%
• Therapeutic Challenges 25%
• Plexiform Neurofibroma 25%
• Area Cover 25%
• Cancer Predisposition Syndrome 25%
• Diagnostic Work-up 25%
• Sarcoma Center 25%
• Targeted Combinational Therapy 25%

Medicine and Dentistry

• Neoplasm 100%
• Neurofibromatosis Type I 100%
• Malignant Peripheral Nerve Sheath Tumor 100%
• Cancer 66%
• Connective Tissue Cancer 66%
• Diagnosis 33%
• Malignant Neoplasm 33%
• Mortality Rate 33%
• Molecular Pathology 33%
• Cancer Susceptibility 33%
• Experimental Therapy 33%
• Plexiform Neurofibroma 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Neoplasm 100%
• Neurofibromatosis Type 1 100%
• Malignant Peripheral Nerve Sheath Tumor 100%
• Connective Tissue Cancer 66%
• Malignant Neoplasm 33%
• Mortality Rate 33%
• Syndrome 33%
• Molecular Pathology 33%
• Cancer Susceptibility 33%
• Neurofibroma 33%